How is Hemicrania Continua diagnosed?

TL;DR: Hemicrania Continua is diagnosed clinically based on the International Classification of Headache Disorders (ICHD-3) criteria, primarily through a patient's response to the medication indomethacin. Because it is a rare, persistent headache disorder, diagnosis often involves a lengthy process of excluding other conditions through neurological exams and brain imaging.

How is Hemicrania Continua diagnosed?

The diagnosis of Hemicrania Continua is essentially clinical, meaning there is no single blood test or genetic marker to confirm it. A neurologist typically follows the ICHD-3 criteria, which require a continuous, strictly unilateral headache lasting more than three months, accompanied by autonomic symptoms (such as tearing or nasal congestion). The definitive diagnostic marker for Hemicrania Continua is a "complete response" to indomethacin, a potent non-steroidal anti-inflammatory drug; if the pain resolves entirely with this treatment, it strongly confirms the diagnosis.

What tests are required to confirm Hemicrania Continua?

While the diagnosis is clinical, physicians must rule out secondary causes of headache. The standard workup usually includes:

• Brain MRI/MRA: To rule out intracranial lesions, tumors, or vascular abnormalities.


• Neurological Examination: To assess nerve function and ensure no underlying pathology is missed.


• Indomethacin Trial: Administered under strict medical supervision due to potential gastrointestinal side effects.


• Blood tests: Generally used only to rule out inflammatory conditions that might mimic Hemicrania Continua.

Why is there a "diagnostic odyssey" for this condition?

Many of the 86 members of our DiseaseMaps community have experienced a long, frustrating path to diagnosis. Hemicrania Continua is frequently misdiagnosed as chronic migraine or cluster headache, leading to years of ineffective treatments. The rarity of Hemicrania Continua means many primary care physicians may never have encountered it, making a referral to a headache specialist or neurologist essential for an accurate assessment.

What are the primary differential diagnoses?

Clinicians must carefully distinguish Hemicrania Continua from other trigeminal autonomic cephalalgias. Key conditions to exclude include:

• Chronic Migraine


• Cluster Headache


• Paroxysmal Hemicrania


• SUNCT/SUNA syndromes

Next steps

• Consult a board-certified neurologist or a fellowship-trained headache specialist.


• Keep a detailed headache diary to track pain intensity and response to medications.


• Join the Hemicrania Continua community at DiseaseMaps.org to connect with others who have navigated this diagnostic journey.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• International Headache Society (ICHD-3): The International Classification of Headache Disorders.


• NIH Genetic and Rare Diseases Information Center (GARD): Hemicrania Continua overview.


• American Migraine Foundation: Resources on indomethacin-responsive headaches.


• Orphanet: Rare disease database entry for Hemicrania Continua.